Abstract

Sacituzumab Govitecan Efficacy in Triple-Negative Breast Cancer

Full Text

Published Version
Open DOI Link

Topics from this Paper

  • Efficacy In Triple-Negative Breast Cancer
  • Triple-Negative Breast Cancer
  • Sacituzumab Govitecan
  • Breast Cancer

Create a personalized feed of these topics

Get Started

Get access to 115M+ research papers

Discover from 40M+ Open access, 2M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Abstract OT1-05-02: Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
  • Cancer Research
  • Mar 1, 2023
Relevant
Not Relevant
Abstract PS4-07: Identification of novel molecules that enhance neratinib efficacy in triple-negative breast cancer by high-throughput RNA interference
  • Cancer Research
  • Feb 15, 2021
Relevant
Not Relevant
Abstract 548: Birinapant enhances gemcitabine's anti-tumor efficacy in triple-negative breast cancer by inducing intrinsic pathway-dependent apoptosis
  • Cancer Research
  • Aug 15, 2020
Relevant
Not Relevant
Abstract 3487: A novel role of transient receptor potential vanilloid type 2 (TRPV2) for augmentation of chemotherapeutic drug efficacy in triple-negative breast cancer
  • Cancer Research
  • Aug 1, 2015
Relevant
Not Relevant
Abstract 4294: Preclinical evaluation of imipridone ONC201 in triple negative breast cancer identifies predictive biomarkers and combinatorial opportunities
  • Cancer Research
  • Jul 1, 2017
Relevant
Not Relevant
Abstract B13: High-risk patients found affected with breast cancer during a multimodality screening program: Triple negative versus non-triple negative breast cancers
  • Cancer Prevention Research
  • Nov 1, 2012
Relevant
Not Relevant
Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model
  • Journal of Medicinal Chemistry
  • Dec 5, 2017
Relevant
Not Relevant
The efficacy and safety of apatinib combined with paclitaxel and carboplatin dose-dense regimen in neoadjuvant therapy for locally advanced triple-negative breast cancer.
  • Journal of Clinical Oncology
  • Jun 1, 2022
Relevant
Not Relevant
Abstract 1078: Dinaciclib overcomes resistance to BKM120 in triple negative breast cancer patient-derived xenograft models
  • Cancer Research
  • Jul 1, 2017
Relevant
Not Relevant
Abstract PD4-05: PD4-05 Integrated multi-cohort profiling identifies CCL19+ dendritic cells to potentiate immunotherapy efficacy in triple-negative breast cancer
  • Cancer Research
  • Mar 1, 2023
Relevant
Not Relevant
In vitro anticancer efficacy of a polyphenolic combination of Quercetin, Curcumin, and Berberine in triple negative breast cancer (TNBC) cells
  • Phytomedicine Plus
  • May 1, 2022
Relevant
Not Relevant
Abstract P5-04-17: Hedgehog pathway is involved in cancer immune surveillance through PDL1 modulation
  • Cancer Research
  • Feb 15, 2020
Relevant
Not Relevant
Abstract 2622: CIP2A mediates the apoptotic effect of bortezomib on triple negative breast cancer cells
  • Cancer Research
  • Apr 1, 2011
Relevant
Not Relevant
CIP2A is a target of bortezomib in human triple negative breast cancer cells
  • Breast Cancer Research
  • Apr 1, 2012
Relevant
Not Relevant
Abstract B16: Lymphatics in triple-negative breast cancer: Contribution to chemotherapeutic efficacy in vitro and in vivo
  • Cancer Research
  • Jul 28, 2016
Relevant
Not Relevant
READ MORE FROM

Oncology Times

How Diabetes May Accelerate Blood Cancer Growth
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
CAR T-Cell Therapy Survival Outcomes Across Ethnicity & Race
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Reproductive Factors Linked to Lung Cancer Risk in Women
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Technique Highlights How Abnormal RNA Splicing Leads to Disease
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
New Treatment Regimen Shows Promise for Bladder Cancer Patients
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Splicing Factor Gene Mutations in Patients With AML
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
An Increase in Early-Onset Cancers Among People Under 50
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Real-World Data From First-Line EGFRm NSCLC Treatment
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Cognitive Effects in Prophylactic Cranial Irradiation for Small Cell Lung Cancer
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant
Soy Expansion Linked to Increase in Childhood Leukemia Deaths
Open Access
Just Published
  • Oncology Times
  • Nov 20, 2023
Relevant
Not Relevant